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Introduction
The occurrence of hyperglycaemia in the acute phase of
stroke has been documented by several studies.1,2A number of
trials have suggested that this is not a benign occurrence and
that admission hyperglycaemia is a risk factor for increased
mortality3-7 and morbidity1,3,8 after stroke. Treatment of
admission hyperglycaemia in post-stroke patients has received
a lot of attention, because it has been recognized that
hyperglycaemia may be a modifiable risk factor for brain
damage.9 Research indicates that strict glycaemic control for
the hospitalized stroke patient is associated with improved
outcome compared with poor control.10,11
In the contemporary literature, various terms have
been used to describe the nature of this hyperglycaemia:
"stress hyperglycaemia",3,10 "reactive hyperglycaemia",12
"post-stroke hyperglycaemia"6 and "admission
hyperglycaemia."13-15Different definitions have been used for
each term but in essence, they constitute a hyperglycaemia
seen after occurrence of a stroke. In the present study, we will
be referring to it simply as admission hyperglycaemia to avoid
any confusion as to the etiology of the hyperglycaemia. 
Coutinho and colleagues concluded on the basis of
their metaregression analysis that patients with dysglycaemia
(blood glucose level above the normal range but below the
threshold for diabetes16) or undiagnosed diabetes have a
higher risk of cardiovascular disease than patients with
normoglycaemia.17 It has been suggested that patients with
admission hyperglycaemia are likely to have dysglycaemia
and are more prone to have ischaemic damage at the time of
infarction as a result of more extensive underlying cerebral
vasculopathy compared with those who do not develop
hyperglycaemia.3 However, the association between
admission hyperglycaemia and the presence and pattern of
intracranial or extracranial vasculopathy has not been studied,
therefore we carried out a study to investigate this relationship. 
Patients and Methods
This retrospective study was conducted at the Aga Khan
University Hospital (AKUH); a major tertiary care hospital in
Karachi, Pakistan. The hospital has a busy neurology service
with a special stroke unit where all patients receive standardized
care according to an established stroke pathway.
Pakistan is a developing South Asian country. It is the
sixth most populated country in the world with a population of
166 million.18 Karachi is the largest city of Pakistan and holds
about 10% of its population.19AKUH receives patients from all
over Karachi.
All acute stroke patients over the age of 14 years are
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Abstract
Objective: To study the association between admission hyperglycaemia and the presence and pattern of
intracranial and extracranial vascular disease. 
Methods: This retrospective study was conducted at a major tertiary care hospital in Karachi, Pakistan. Patients
who had presented with acute stroke and had undergone a carotid ultrasound doppler of the carotids and/or
Magnetic Resonance Angiography (MRA) of the brain were included in the study. A multiple logistic regression
analysis of variables was done for an abnormal finding on each investigation.
Results: Out of the total of 216 patients, the age of majority of the patients (83.3%) was >50 years and 134 (62%)
were male. One hundred and fourteen patients (52.8%) had admission hyperglyaemia. Multiple logistic
regression analysis revealed that increasing age and admission hyperglycaemia (P=0.045, Odds ratio=1.9 [95%
CI: 1.0-3.6]) were independent predictors of an abnormal finding on a carotid doppler investigation. Admission
hyperglycaemia did not predict the presence of general intracranial vasculopathy but it was significantly
associated with focal stenosis as visualized on a MRA. 
Conclusion: Admission hyperglycaemia is associated with large vessel disease manifesting itself in the
carotids as plaques and in the intracranial circulation as focal stenosis. Acute stroke patients presenting with
admission hyperglycemia would require a more careful investigation for large artery disease especially in the
extracranial vessels (JPMA 59:328; 2009).
enrolled in the Aga Khan University Stroke Data Bank were
scrutinized. All patient information was obtained from here,
for the study.
Patients with subarachnoid, subdural or epidural
haemorrhage are excluded from the Data Bank. Therefore
patients who were not investigated with either Magnetic
Resonance Angiography (MRA) of the head or carotid
doppler ultrasonography were excluded. 
Institutional Ethical Review Committee (ERC) cleared
this retrospective review. The data collection was done by
neurology housestaff on a standardized data entry form. The data
was collected during the patient's hospital stay and the patient's
discharge was the end point for the purpose of this study.
Neurological Definitions
Acute stroke was defined as rapidly evolving focal or
global loss of cerebral function with symptoms leading to
death or lasting more than 24 hours due to a vascular etiology.
Hypertension was defined as a past medical history of
hypertension (whether treated or not) or electrocardiographic
or echocardiographic evidence of hypertension. 
Diabetes Mellitus was defined as a past medical
history of diabetes mellitus or sustained blood sugar elevation
requiring treatment with hypoglycaemic agents or insulin
throughout hospitalization.
Admission hyperglycaemia was defined as venous
blood random blood glucose levels over 150mg/dl within 3
hours of admission.
Abnormal cholesterol elevation was defined as history
of high cholesterol in the past or documentation of elevated
cholesterol during hospital stay.
Coronary artery disease was defined as clinical
evidence of ischaemic heart disease and/or a history of
myocardial infarction.
The three patterns of intracranial vasculopathy
documented on the MRA were:
Diffuse atherosclerosis, focal stenosis of a specific
region and focal occlusion.
Outcomes
The following two outcomes were investigated
independently of each other.
An abnormal MRA of the head was interpreted as
intracranial vasculopathy. A variant of normal intracranial
vasculature was not read as an abnormal MRA, but was
included in normal MRAs.
An abnormal carotid doppler ultrasonograph was
interpreted as extracranial vasculopathy.
The NASCET criteria were used to define moderate
and severe stenosis on ultrasound.20
Statistical Analysis
Data was entered and analyzed using the Statistical
Package for Social Sciences 14.0 (SPSS, Inc., Chicago, IL,
USA). Descriptive statistics were performed. Results were
recorded as frequencies, means ± standard deviations (SD)
and P values. A p value of <0.05 was taken as the criteria of
significance for all purposes.
Univariate analysis was done utilizing the chi square
test and Fisher's exact test for categorical variables. The
independent samples t-test was used for continuous variables.
The variables which were biologically meaningful or had a p
value of less than 0.25 on univariate analysis were subjected
to a stepwise multiple logistic regression analysis to determine
which factors were independent predictors of abnormal
vasculopathy.20 The Hosmer and Lemeshow goodness-of-fit
test was also used to determine the final model.21 Unadjusted
as well as adjusted odds ratios were recorded.
Results
During the study period, there were 596 patients
enrolled in the AKUH Stroke Data Bank. Out of these, 380
patients were excluded because they fulfilled the exclusion
criteria, leaving 216 patients who had been investigated with
either MRA of the head or carotid doppler ultrasonography of
the carotids.  
Of the 216 patients, 124 (57.4%) had been investigated
with a MRA study and 172 (79.6%) with a carotid doppler
ultrasonography. Of the 124 patients who were investigated
with MRA, 33 (26.6%) had an abnormal finding compared to
83 (48.3%) of the 172 who were investigated with carotid
doppler ultrasonography. 
The age of majority of the patients (83.3%) was greater
than or equal to 50 years. One hundred and thirty four (62.0%)
of the 216 patients were male. Of the 216 patients, 114
(52.8%) had admission hyperglycaemia and 91 (42.1%) were
either previously diagnosed diabetics or were diagnosed with
diabetes during hospitalization. Majority of these diabetics
(79.1%) had presented with admission hyperglycaemia. A
sizable proportion of patients (33.6%) who were not
previously diagnosed diabetics or treated as diabetics during
hospital stay, had presented with admission hyperglycaemia. 
Univariate analysis was performed for both outcomes
separately to study the association of the individual factors
with each outcome. The multiple logistic regression analysis
models were based on these results.  
Multiple logistic regression analysis revealed that
increasing age and admission hyperglycaemia (P=0.045, Odds
ratio=1.9 [95% CI: 1.0-3.6]) were independent predictors of
an abnormal finding on a carotid doppler investigation (Table
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1). Hypertension was marginally significant as a negative
predictor of an abnormal finding on a carotid doppler
ultrasonograph (p = 0.06, Odds ratio=0.5 [95% CI: 0.3-1.0]).
The multiple logistic regression analysis model included age,
admission hyperglycaemia, diabetes and hypertension.
The regression analysis revealed that coronary artery
disease was an independent predictor of an abnormal MRA (p
= 0.033, Odds ratio=2.7 [95% CI: 1.1-1.6]) (Table 1). Age,
ischaemic heart disease and type of stroke were included in the
multiple logistic regression analysis models. 
The three patterns of intracranial vasculopathy
documented were diffuse atherosclerosis, focal stenosis of a
specific region and focal occlusion. In the 14 patients with
diffuse atherosclerosis, 8 (57.1%) had admission
hyperglycaemia. In patients with focal stenosis, 13/15 (86.7%)
had admission hyperglycaemia, compared to 3/10 (30%) of
those who had focal occlusion. A significantly greater number
of patients with focal stenosis had admission hyperglycaemia
(p = 0.010) (Table 2). 
Patterns of vasculopathy in the carotids were
documented according to the location of the plaque. The
proportion of patients with admission hyperglycaemia was
same in patients with a plaque in either the right or the left
internal carotid artery (ICA): 66.7% (Table 3). Admission
hyperglycaemia was significantly associated with presence of
plaques in either right or left ICA (p = 0.021).
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Table 1: Multiple logistic regression analysis showing independent predictors of abnormal carotid doppler findings and abnormal MRA findings.
Variables Normal carotid doppler (n=89) Abnormal carotid doppler (n=83) Adjusted OR* CI **
Age  (P value = 0.006)
< 45 years 8 (9%) 1 (1.2%) 1
45 - 59 years 32 (36%) 18 (21.7%) 5.0 0.6-45.8
> 59 years 49 (55.1%) 64 (77.1%) 12.5 1.4-110.3
Admission hyperglycaemia (P value= 0.045)
No 50 (56.2%) 32 (38.6%) 1
Yes 39 (43.8%) 51 (61.4%) 1.9 1.0-3.6
Hypertension (P value= 0.06)
No 28 (31.5%) 33 (39.8%) 1
Yes 61 (68.5%) 50 (60.2%) 0.5 0.3-1.0
Variables Normal MRA (n=91) Abnormal MRA (n=33) Adjusted OR* CI **
Age (P value= 0.077)
< 45 years 8 (8.8%) 8 (24.2%) 1
45 - 59 years 33 (36.3%) 10 (30.3%) 0.3 0.1-1.1
> 59 years 50 (54.9%) 15 (45.5%) 0.3 0.1-0.9
Ischaemic Heart disease (P value= 0.033)
No 72 (79.1%) 20 (60.6%) 1
Yes 19 (20.9%) 13 (39.4%) 2.7 1.1-6.6
* OR = Odds Ratio
** CI = Confidence Interval 95%
Table 2: Association between admission hyperglycaemia and the nature of intracranial vasculopathy.
Diffuse atherosclerosis* Focal stenosis of specific region* Focal  occlusion*
+ - + - + -
Admission hyperglycemia present 8 (57.1%) 61   (55.5%) 13 (86.7%) 56 (51.4%) 3 (30%) 66 (57.9%)
Admission hyperglycemia absent 6 (42.9%) 49 (44.5%) 2 (13.3%) 53 (48.6%) 7 (70%) 48 (42.1%)
P value 0.905 0.010 0.107
* The three patterns of intracranial vasculopathy are not mutually exclusive.
Table 3: Association between admission hyperglycaemia and location of extracranial vasculopathy.
Plaque in right ICA only Plaque in left ICA only Plaque in either ICA Plaque in both ICAs
+ - + - + - + -
Admission hyperglycaemia present 14 (66.7%) 76 (50.3%) 14 (66.7%) 76 (50.3%) 51 (61.4%) 39 (43.8%) 23 (56.1%) 67 (51.1%)
Admission hyperglycaemia absent 7 (33.3%) 75 (49.7%) 7 (33.3%) 75 (49.7%) 32 (38.6%) 50 (56.2%) 18(43.9%) 64 (48.9%)
P value 0.160 0.160 0.021 0.580
Discussion
This study investigated the association between
admission hyperglycaemia and intracranial as well as
extracranial vasculopathy and found that admission
hyperglycaemia was an independent predictor of
extracranial vascular disease, manifested as an abnormality
on doppler ultrasonography of the carotids. Admission
hyperglycaemia did not independently predict intracranial
vasculopathy. However, it was significantly associated with
focal stenosis on the MRA.
Diabetes causes damage to intracranial as well as
extracranial vessels.22 However, recent research shows that a
definite relationship exists between blood glucose levels
below the diabetic threshold and both macro- and
microvascular disease, independent of a patient's progression
to diabetes.23 Patients with admission hyperglycaemia include
diagnosed as well as undiagnosed diabetics. It is known that
the prevalence of recognised diabetes mellitus in acute stroke
patients is between 8 and 20%, but around 6 to 42% of patients
may have undiagnosed diabetes mellitus before
presentation.24 Our study showed that the subset of patients
with diagnosed as well as undiagnosed diabetes comprised
42.1% of the total number of acute stroke patients. The
majority (79.1%) of this subset of patients recorded an
admission hyperglycaemia.
Increasing age and admission hyperglycaemia were
both found to independently predict extracranial vasculopathy.
This vascular disease was detected on doppler
ultrasonography of the carotids. The implications of this
finding are limited in their worth because the mere presence of
a plaque does not necessarily mean that the patient is
symptomatic because of it. The degree of stenosis caused by
the plaque is more predictive of positive symptomatology.
Any positive association between admission hyperglycaemia
and critically stenosed carotids might have been more
valuable. Unfortunately, the degree of stenosis was not
documented for each plaque detected on the ultrasound.
Despite this shortcoming, the presence of admission
hyperglycaemia mandates careful investigation for carotid
disease.
We did not find a significant association between the
presence of coronary artery disease and extracranial ICA
atherosclerosis. This is not concurrent with other studies
which showed a high prevalence of asymptomatic CAD in
patients with extracranial ICA atherosclerosis.25
Admission hyperglycaemia did not predict the
presence of general intracranial vasculopathy but it was
significantly associated with focal stenosis as visualized on a
MRA. The only independent predictor of intracranial
vasculopathy was coronary artery disease. 
Our study had a number of limitations which merit
discussion. This study was conducted at one institute only and
the prevalence of admission hyperglycaemia in acute stroke
patients may vary significantly at different institutes. This
somewhat restricts the generalisability of the results. The
retrospective study design has some inherent limitations. The
unavailability of data on the degree of stenosis of carotid
arteries limits the value of the predictive capability of
admission hyperglycaemia for the presence of stenosis. The
findings of the study must be interpreted in a prudent manner.
Conclusion
Admission hyperglycaemia is associated with large
vessel disease manifesting itself in the carotids as plaques and
in the intracranial circulation as focal stenosis. Acute stroke
patients presenting with admission hyperglycaemia would
require a more careful investigation for large artery disease
especially extracranial vascular disease. Multicentre
prospective studies are required to explore this relationship
further.
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